Pharma sees climate disruption as growing supply-chain risk
British Standards Institution, climate disruption, pharma, supply-chain risk
Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to their supply chains to increase …
Manchester NHS-MHRA partnership to test new technologies in real-world care
September 10, 2026AI-enabled medical devices, Manchester, NHS-MHRA partnership, patient care
Patients in Manchester could gain faster access to promising healthcare technologies through a new partnership between the Medicines and Healthcare …
Ondine reports 40% reduction in surgical-site infections in phase 3 trial
September 9, 2026Ondine Biomedical, nasal photodisinfection technology, phase 3 trial, surgical-site infections
Ondine Biomedical has reported a 40% relative reduction in 30-day surgical-site infections (SSIs) in a 5,188-patient phase 3 trial of …
Northern Ireland to roll out staff well-being training across health service
September 8, 2026Northern Ireland Health and Social Care, staff well-being training
Thousands of line managers across Northern Ireland’s Health and Social Care (HSC) system are to receive new training designed to …
European consortium demonstrates continuous manufacturing platform for pharmaceutical ingredients
September 7, 2026European PIPAC consortium, continuous manufacturing platform, supply-chain resilience
A European consortium has demonstrated a continuous manufacturing platform for pharmaceutical active ingredients (APIs), combining continuous-flow chemistry, real-time analytical monitoring …
From lab breakthrough to NHS treatment: Getting innovative therapies to patients
September 5, 2026Clinical trials supplies & documentation logistics, Due Diligence, NICE / SMC Submissions, Pharmacovigilance, Regulatory Affairs Oncology
By Chloe Williams and Sarah Ellson Innovative therapies are transforming the treatment landscape for serious diseases, particularly cancer. Advances in …
Five Facts about NHS and primary care
September 5, 2026Medical Communications Five Facts, HRT, NHS, primary care
1 Primary care is the front door to the NHS, but it extends well beyond general practice. It includes primary …
Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.
September 5, 2026Clinical & Scientific, Clinical Research, Clinical Trial Services, Clinical research Training, Clinical trial specialist packaging, Data Capture Asthma & COPD, Chronic Diseases, Immunology, Rare Diseases, Sample integrity, clinical trials, enrolment
By Dr. Richard Graham Industry conversations about clinical trial participation tend to focus on awareness, access, and willingness to enrol. …
AI in pharma: From lab development to patient impact
September 5, 2026AI, Cancer, Immunology, Merck, Vaccine, Virology, personalised medicine, pharma
In the decade to 2025, AI use in vaccine development has increased markedly but is the boom in research translating …
Back to basics: X-ray inspection in pharmaceutical and medical device production
September 5, 2026Licences/Quality Standards, Packaging, Pharmacovigilance Contamination Control, Devices, inspection, pharmaceutical manufacturing, regulatory
By Adam Green In pharmaceutical manufacturing, inspection plays a critical role in process control to examine individual products, primary packs, …
Power of partnership: Turning shared purpose into improved shared decision-making in rare disease
September 5, 2026Internal Communication Campaigns, Market Access Consultancy, Medical Communications, Medical Communications Training, Patient Advocacy Rare Diseases, ZPB Associates
In February 2026, PMGroup Worldwide Ltd and Visions4Health launched the Excellence in Healthcare Partnerships (EHP) Awards to recognise innovative collaborations …
Major funding opportunity opens for early cancer diagnostics
September 4, 2026Innovate UK, NHS, Scotland, cancer research funding
Up to £25.4m in funding is available for collaborative projects developing technologies to improve the early detection and diagnosis of …
Androlabs receives UK authorisation for new Testavan presentation
September 4, 2026Androlabs, Testavan, UK authorisation, hypogonadism, testosterone
Androlabs has received UK marketing authorisation for a new presentation of Testavan 4.6 mg/actuation transdermal gel for testosterone replacement therapy …
CEPI backs African-led Bundibugyo Ebola vaccine development
September 3, 2026Africa, CEPI, Ebola vaccine
Minapharm Group is to receive up to US$16.5m from the Coalition for Epidemic Preparedness Innovations (CEPI) to advance development of …
Cytomos appoints life sciences executive to board
September 2, 2026Alex Jones, Cytomos, non-executive director
Edinburgh-based biotechnology company Cytomos has appointed life sciences executive Dr Alex Jones as a non-executive director as it moves to …
Cell therapy partnership aims to bring liver disease treatment closer to US patients
September 1, 2026Resolution Therapeutics, US, cell therapy, liver disease
Resolution Therapeutics has partnered with the Blood Centers of America (BCA) to support community-based delivery of its experimental cell therapy …
Scots neonatal innovations target hearing loss and earlier care
August 28, 2026NHS, Scottish healthcare, hearing loss, neonatal innovations
Scottish healthcare teams are introducing a range of innovations aimed at improving outcomes for newborns, including a rapid genetic test …
FDA grants De Novo authorisation to light-filtering device for migraine
August 28, 2026De Novo, FDA, light-filtering device, migraine
The US Food and Drug Administration (FDA) has granted De Novo marketing authorisation to Avulux, a precision optical filter designed …
Southgate opens Innovation Lab for logistics and fulfilment development
August 27, 2026Southgate Global, UK Innovation Lab, fulfilment and manufacturing operations, logistics
Southgate Global has opened its first UK Innovation Lab, creating an in-house facility for developing and testing equipment and practical …
Bioptimus partners with Cancer Research Horizons to expand AI cancer data set
August 27, 2026AI, Bioptimus, Cancer Research Horizons, Cancer Research UK, colorectal cancer
Bioptimus has partnered with Cancer Research Horizons, the innovation arm of Cancer Research UK, to give the AI biotechnology company …
Agentis Health Group acquires Clinical Pharmacist Solutions
August 26, 2026Agentis Health Group, CQC, Clinical Pharmacist Solutions, NHS
Agentis Health Group has acquired Clinical Pharmacist Solutions (CPS), strengthening its pharmacy and digital health business as the NHS expands …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
